- $3.40bn
- $3.91bn
- $1.06bn
- 79
- 26
- 81
- 65
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,206 | 800 | 840 | 1,099 | 1,059 |
Cost of Revenue | |||||
Gross Profit | 404 | 286 | 328 | 423 | 427 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,149 | 771 | 775 | 1,027 | 983 |
Operating Profit | 56.6 | 29.1 | 65.4 | 72.2 | 76.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.3 | -23.5 | 66 | 28.3 | 37.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.8 | -21 | 57.3 | 3.9 | 6.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 38.3 | 178 | 178 | 205 | 22.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 38.3 | 178 | 178 | 205 | 22.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.13 | -1.23 | 3.12 | 2.66 | 2.73 |
Dividends per Share |